Related Experiment Video
Updated: May 6, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Microglia actions in Alzheimer’s disease
Abstract:
The identification of microglia-associated, neurological disease-causing mutations in patients, combined with studies in mouse models has highlighted microglia, the brain’s intrinsic myeloid cells, as key modulators of pathogenesis and disease progression in neurodegenerative diseases. In Alzheimer’s disease (AD) in particular, the activation and accumulation of microglial cells around b-Amyloid (Ab) plaques has long been described and is believed to result in chronic neuroinflammation—a term that, despite being commonly used, lacks a precise definition. This seemingly directed response of microglia to amyloid deposits conflicts with the fact that the increasing buildup of Ab plaques is not inhibited by these cells during disease progression. While recent evidence suggests that microglia lose their intrinsic beneficial function during the course of AD and may even acquire a ‘‘toxic’’ phenotype over time, Ab may also simply not be an appropriate trigger to induce phagocytosis and degradation by microglia in vivo. As recent experimental evidence has indicated the importance of the microglia in AD pathogenesis, future efforts aimed at tackling this disease via utilization or modulation of microglia or factors therefrom appear to be an exciting and challenging research front.
Insights
Microglia, the brain's immune cells, play a critical role in neurodegenerative diseases like Alzheimer's. Understanding their complex response to amyloid plaques is key to developing new therapeutic strategies.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the brain’s intrinsic myeloid cells, are implicated in neurodegenerative disease pathogenesis.
- In Alzheimer’s disease (AD), microglia accumulate around amyloid-beta (Aβ) plaques, contributing to neuroinflammation.
- The precise role and phenotype of microglia in AD progression remain incompletely understood.
Purpose of the Study:
- To explore the multifaceted role of microglia in Alzheimer’s disease pathogenesis.
- To investigate the interaction between microglia and amyloid-beta plaques.
- To highlight microglia as a potential therapeutic target for AD.
Main Methods:
- Review of existing literature on microglia in neurodegenerative diseases.
- Analysis of studies involving patient-derived mutations and mouse models.
- Examination of the microglial response to amyloid-beta deposits in vivo.
Main Results:
- Microglia are identified as key modulators in the progression of neurodegenerative diseases.
- The microglial response to amyloid-beta plaques in AD is complex and may not effectively clear plaques.
- Evidence suggests microglia may lose beneficial functions and adopt detrimental phenotypes in AD.
Conclusions:
- Microglia are central to AD pathogenesis, exhibiting a complex and evolving role.
- Targeting microglia or their secreted factors presents a promising, albeit challenging, avenue for AD therapeutics.
- Further research into microglial function and modulation is crucial for advancing AD treatment strategies.
More Related Videos
07:54Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment
01:29Alzheimer Disease l: Introduction
01:04Glial Cells